SCHEMBL114405

SCHEMBL114405

Cc1cc(C)n(C(C=O)N2CCN(c3ccccc3-c3cnc(N4CCN(C)CC4)nc3)CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.39
KCNH2 Q12809 1/20 0.39
TNKS O95271 2/20 0.39
KMT2A Q03164 2/20 0.35
EGFR P00533 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
TNK2 Q07912 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113125 0.94 CXCR3 (0.40) CXCR3KCNH2TNKSMAPTMAPK1
SCHEMBL114041 0.93 CXCR3 (0.39) CXCR3KCNH2TNKSMAPTMAPK1
SCHEMBL112035 0.91 CNR2 (0.42) CXCR3KCNH2AOC3TSHRHSD17B10
SCHEMBL113141 0.90 CXCR3 (0.38) CXCR3KCNH2TNKSMAPTHTR1A
SCHEMBL115477 0.89 CXCR3 (0.42) CXCR3KCNH2MAPTHTR1AUSP2
SCHEMBL114718 0.89 CXCR3 (0.39) CXCR3KCNH2TNKSTNK2F10
SCHEMBL114021 0.89 CXCR3 (0.37) CXCR3KCNH2HDAC3HDAC4HDAC1
SCHEMBL114565 0.88 CXCR3 (0.36) CXCR3KCNH2TNKSEGFRHDAC3
SCHEMBL115833 0.88 CXCR3 (0.41) CXCR3KCNH2
SCHEMBL111097 0.88 CXCR3 (0.37) CXCR3KCNH2KMT2AHTR1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed